# Effectiveness of Anti-Psychotic in GPs Setting

> **NCT00543088** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 250 (—)

## Conditions studied

- Schizophrenia
- Bipolar Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00543088
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** —
- **Final completion:** 2008-06
- **Target enrollment:** 250 (—)
- **Last updated:** 2009-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00543088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00543088, "Effectiveness of Anti-Psychotic in GPs Setting". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00543088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*